Clinical Trial

Remimazolam Consumption: TCI vs. Manual Infusion

Name: Remimazolam Consumption: TCI vs. Manual Infusion — clinical trial record (NCT07377695)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this prospective randomized controlled trial is to compare the total consumption of remimazolam between two different administration methods-Target-Controlled Infusion (TCI) and manual infusion-in patients undergoing cerebrovascular bypass surgery.

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-24

Trial Details

NCT Number	NCT07377695
Lead Sponsor	Seoul National University Hospital
Conditions	Moyamoya Disease
Enrollment	58 participants
Start Date	2026-02-04
Primary Completion	2026-12-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-23